Prenatal Testing and Newborn Screening Market to Record Steadfast Evolution Through 2020-2027 By Emergen Research

Prenatal Testing and Newborn Screening Market
Prenatal Testing and Newborn Screening Market

According to a recent report by Emergen Research, the global prenatal testing and newborn screening market is expected to be worth USD 10.85 billion by 2027. Due to its expanding use in identifying foetal chromosomal abnormalities, prenatal testing and newborn screening are in high demand. Prenatal testing is thought to be better than other screening methods, especially for trisomy 21. (one of the most prevalent congenital anomalies). Individuals can use prenatal testing to decide for themselves whether diagnostic testing is necessary. The genetic material that is present or absent in associated foetal chromosomal abnormalities can range from tiny portions of chromosomes to complete chromosomes.

The market for prenatal testing and newborn screening is driven by growing demand among expectant mothers as an alternative to amniocentesis and knowledge of genetic issues in the foetus and newborn newborns.

The prenatal testing and newborn screening market, which is expanding rapidly, is the subject of this study. The research provides a roadmap for the prenatal testing and newborn screening market, which will influence how we live in the coming ten years and beyond. It also discusses how the market will respond to the threat of the global pandemic.

Download FREE Sample PDF Report

Some Key Highlights from the Report

  • A non-invasive, tailored prenatal test for monogenetic illnesses called the Resura Prenatal Test was announced by Progenity Inc. in April 2019.
  • Due to the potential of ultrasound diagnosis to detect irregularities in the location of the foetus and actions within the womb, ultrasound technology is expected to see a large growth rate during the projection period.
  • Due to the expanding use of non-invasive prenatal testing, quick technological advancements in newborn screening, the presence of qualified personnel, and better reimbursement conditions, the hospital held a sizable market share in 2019.
  • Due to the availability of cutting-edge healthcare research systems and advancements in whole-genome sequencing, North America dominated the market for prenatal testing and newborn screening in 2019

Key participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others

Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Prenatal Testing
  • Newborn Screening

Test Type Outlook (Revenue, USD Billion; 2017-2027)

  • Non-Invasive
  • Invasive

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Mass Spectrometry
  • Electrophoresis
  • Enzyme Immunoassays
  • DNA Assays

Instrument Outlook (Revenue, USD Billion; 2017-2027)

  • Ultrasonography
  • Reagent and Assay Kits
  • Tandem Quadrupole Detector
  • Incubator Shaker
  • Hearing Screen Instruments

End Users Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Maternity & Specialty Clinics
  • Diagnostic Centers

Regional Outlook (Revenue, USD Billion; 2017-2027)

    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Browse the complete Global Prenatal Testing and Newborn Screening Market Research Report – Industry Analysis, Size, Share, Growth, [email protected]

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Skin Lightening Market | Kitchen Appliances Market

Latest Reports: Stevia Market | Blockchain Technology Market

You may also like...

Leave a Reply

Your email address will not be published.